Compare Multipolar Tbk. (MLPL) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Multipolar Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Multipolar Tbk. trades at Rp90 (market cap 1.41T, 18.17M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Multipolar Tbk. is far larger — about 13.5× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| MLPL | SCPI | |
|---|---|---|
Market Cap | 1.41T | 104.4B |
Volume | 18.17M | — |
Lot | 181.74K | — |
Turnover | 1.62B | — |
Average Price | 89.32 | — |
Value | 1.62B | — |
Indicative Equilibrium Price | 90 | — |
Indicative Equilibrium Volume | 1.66K | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Multipolar Tbk.
PT Multipolar Tbk (the Company) was established in the Republic of Indonesia on December 4, 1975 based on Notarial Deed No. 7 of Adlan Yulizar, S.H., which has beed amended several times, the latest by Notarial Deed No. 119 of Misahardi Wilamarta, S.H., dated March 25, 1982.
Read more on MLPL →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
